Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-CTx-Ag01 | Recombinant human | 3090 |
GMP-h-CTx-Ab01 | Anti-human | 1953 |
GMP-h-CTx-Ab02 | Anti-human | 1953 |
GMP-h-CTx-Ab03 | Anti-human | 1953 |
GMP-h-CTx-Ab04 | Anti-human | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-h-CTx-Ag01 |
Product Name | Recombinant human |
Target/Biomarker | () |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | () antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in level test of Metabolic diseases (osteoporosis) and related syndrome evaluation. |
Products description | Recombinant human was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-CTx-Ab01, GMP-h-CTx-Ab02, GMP-h-CTx-Ab03, GMP-h-CTx-Ab04 |
Product Name | Anti-human |
Target/Biomarker | () |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human () antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other () antibodies in level test of Metabolic diseases (osteoporosis) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Bone is a metabolically active tissue, and almost 10% of the adult bone is remodeled every year. Bone remodeling comprises bone resorption and formation. During the remodeling process, the activity of osteoblasts and osteoclasts results in the release of proteins or peptides. The peptide products are either proteins released by the cells, such as bone-specific alkaline phosphatase (BAP) and osteocalcin (OC) or degradation products of cellular activity, such as urinary hydroxyproline, deoxypyridinoline,
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments